|

Brazilian Prospective Registry of the Inspiron EVO Drug-Eluting Stent in Complex Coronary Lesions

RECRUITINGSponsored by Scitech Produtos Medicos SA
Actively Recruiting
SponsorScitech Produtos Medicos SA
Started2026-10-30
Est. completion2030-10-30
Eligibility
Age18 Years+
Healthy vol.Accepted

Summary

The objective is to evaluate the efficacy and safety of the Inspiron™ EVO drug-eluting stent in complex coronary lesions in a real-world population. Patients with symptomatic ischemic heart disease due to lesions in native coronary arteries and restenotic lesions will be treated with the Inspiron™ EVO drug-eluting stent.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Individuals aged 18 years or older presenting with complex coronary lesions requiring percutaneous coronary intervention (PCI).
* Individuals who provide consent and are willing to comply with the follow-up protocol.
* Individuals who received treatment with the Inspiron™ EVO Stent.
* Individuals with lesions ≥ 30 mm in length (Subprotocol 1).
* Individuals with significantly calcified coronary lesions (moderate to severe according to the ACC/AHA classification B1, B2, or C), with or without indication for lesion preparation techniques (Subprotocol 2).
* Individuals with multivessel coronary artery disease (≥2 affected coronary vessels, with at least one vessel of small diameter ≤2.5 mm) (Subprotocol 3).
* Individuals included in Subprotocol 1, 2, or 3. The evaluated segment must be accessible to the IVUS (Intravascular Ultrasound) catheter (Subprotocol 4).

Exclusion Criteria:

* Lesions in saphenous vein grafts or internal mammary grafts.
* Contraindication to the use of a drug-eluting stent.
* Individuals who were treated during the index procedure with any stent other than the Inspiron™ EVO Stent.

Conditions7

Calcific Coronary ArteriosclerosisComplex Coronary LesionsCoronary Artery Disease (CAD)Heart DiseaseMultivessel Coronary Artery DiseaseSmall Vessel Ischemic DiseaseStenosis Coronary

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.